Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
42 studies found for:    reach2hd
Show Display Options
Rank Status Study
1 Completed Effect of PBT2 in Patients With Early to Mid Stage Huntington Disease
Condition: Huntington Disease
Interventions: Drug: PBT2;   Drug: Placebo
2 Completed
Has Results
The Effect of Rituximab on Mobilization With AMD3100 (Plerixafor) Plus G-CSF in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma (NHL) or Hodgkin Disease (HD)
Conditions: Non-Hodgkin Lymphoma;   Hodgkin Disease
Interventions: Drug: G-CSF plus plerixafor;   Biological: rituximab
3 Completed Evaluation of the Safety and Efficacy of the Addition of AMD3100 to a G-CSF Mobilization Regimen in Patients With Lymphoma (NHL and HD) and Multiple Myeloma (MM).
Conditions: Lymphoma;   Non Hodgkin's Lymphoma;   Hodgkin's Disease;   Multiple Myeloma
Interventions: Drug: Plerixafor (AMD3100);   Drug: Can be any registered nonpegylated form of G-CSF
4 Completed
Has Results
Pharmacokinetics And Dialysability Of CP-690,550 In Subjects With End-Stage Renal Disease
Conditions: End-Stage Renal Disease;   Hemodialysis
Intervention: Drug: CP-690,550
5 Recruiting A Phase 2a Study To Evaluate The Pharmacokinetics, Safety, Efficacy, Tolerability, And Pharmacodynamics of Sotatercept (ACE-011) for the Correction of Anemia in Subjects With End-stage Renal Disease on Hemodialysis.
Condition: Anemia
Interventions: Biological: Sotatercept;   Biological: Placebo
6 Completed
Has Results
AMD3100 (Plerixafor) Added to a Mobilizing Regimen of Granulocyte-colony Stimulating Factor (G-CSF) to Increase the Number of Peripheral Blood Stem Cells (PBSCs) in Patients With Hodgkin's Disease
Condition: Hodgkin's Disease
Intervention: Drug: G-CSF Plus Plerixafor
7 Completed Multi-dose Pharmacokinetics and Dose Ranging of Inositol in Premature Infants (INS-2)
Conditions: Infant, Newborn;   Infant, Low Birth Weight;   Infant, Small for Gestational Age;   Infant, Premature;   Retinopathy of Prematurity;   Bronchopulmonary Dysplasia (BPD)
Interventions: Drug: Inositol lower volume;   Drug: Inositol mid-level volume;   Drug: Inositol high volume;   Drug: Placebo low volume
8 Unknown  The "Reach For Health" Program: Delaying Sexual Activity in Children
Conditions: Sex Behavior;   Child Behavior
Interventions: Behavioral: Parent-child communication education;   Behavioral: Service learning;   Behavioral: Classroom health curriculum
9 Active, not recruiting A Study of Belimumab in Idiopathic Membranous Glomerulonephropathy
Condition: Glomerulonephritis, Membranous
Intervention: Drug: belimumab
10 Completed Improving Mental Health Services for Economically Disadvantaged Children: Training Teachers
Condition: Psychopathology
Intervention: Behavioral: Reaching Educators, Children, and Parents (RECAP)
11 Terminated
Has Results
A Study of RoActemra/Actemra (Tocilizumab) in Patients With Ankylosing Spondylitis Who Have Failed Treatment With NSAIDs
Condition: Spondylitis, Ankylosing
Interventions: Biological: tocilizumab;   Drug: Placebo
12 Completed Comparison of a Basal Plus One Insulin Regimen With a Biphasic Insulin Regimen in Type 2 Diabetes Patients
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: INSULIN GLARGINE (HOE901);   Drug: Insulin aspart;   Drug: Insulin Glulisine
13 Recruiting Evaluate the Safety, Pharmacodynamics, Pharmacokinetics, and Exploratory Efficacy of GZ/SAR402671 in Treatment-naïve Adult Male Patients With Fabry Disease
Condition: Fabry's Disease
Intervention: Drug: GZ/SAR402671
14 Completed Pharmacokinetic Properties of Isosorbide-5-mononitrate Under Fasting and Fed Condition in Healthy Male Subjects
Condition: Healthy
Interventions: Drug: Elantan SR 60 mg;   Drug: Imdur SR 60 mg
15 Completed Dose Finding Study to Treat High Phosphate Levels in the Blood.
Condition: Hyperphosphatemia
Interventions: Drug: AZD1722;   Drug: Placebo
16 Recruiting Biomarker-based Exclusion of VAP for Improved Antibiotic Stewardship
Condition: Ventilator-associated Pneumonia
Intervention: Other: Biomarker-based diagnostic
17 Terminated POC in Patients With Ischaemic Stroke
Condition: Cerebrovascular Accident
Interventions: Drug: GSK249320 100/mg;   Drug: Placebo
18 Completed Trial of Aggressive Versus Conservative Phototherapy in Infants <1,000 Grams Birth Weight
Conditions: Hyperbilirubinemia, Neonatal;   Jaundice, Neonatal;   Infant, Newborn;   Infant, Low Birth Weight;   Infant, Small for Gestational Age;   Infant, Premature
Interventions: Procedure: Aggressive Phototherapy 501-750g;   Procedure: Aggressive Phototherapy 751-1000g;   Procedure: Conservative Phototherapy 501-750g;   Procedure: Conservative Phototherapy 751-1000g
19 Completed Open Label Study Assessing Effectiveness Of Amlodipine/Atorvastatin In Subjects With Hypertension and Dyslipidaemia
Conditions: Hypertension;   Dyslipidemia
Intervention: Drug: Amlodipine/Atorvastatin
20 Completed Determination of a Questionnaire After Treatment With Pantoprazole at Full Dose and Half Dose in Adult Patients With Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/UK-506)
Conditions: Gastroesophageal Reflux;   GERD;   GORD
Intervention: Drug: Pantoprazole

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years